Description
SARS-CoV-2 Spike S1 (B.1.1.529) Specific ELISA Kit (For Vaccine Development) | RAS-A170| Gentaur Distribution US, UK & Europe
The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike S1 is urgently needed to accelerate the development of COVID-19 vaccines.
Source: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike S1 is urgently needed to accelerate the development of COVID-19 vaccines.
Molecule: Spike S1.
Format: Solid.
Species: SARSN/ACoVN/A2.
Application: The kit is developed for specific detection of SARS-CoV-2 Spike S1 (B.1.1.529) in vaccine samples, witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quality control, and realize accurate quantification of vaccine antigen contents for COVID-19 vaccines of Omicron-specific boosters.
Kit Component: This assay kit employs a standard sandwich-ELISA format, providing a rapid detection of SARS-CoV-2 Spike S1.The kit consists of microplate pre-coated with Anti-SARS-CoV-2 Spike S1 Antibody, SARS-CoV-2 Spike S1 as Control, HPR-Anti-SARS-CoV-2 Spike S1 Antibody and buffers.
Stability: 1. Unopened kit should be stored at 2℃-8℃ upon receiving. 2. Find the expiration date on the outside packaging and do not use reagents past their expiration date. 3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Storage Conditions: 2-8℃.
Shipping Conditions: Blue ice
